Home > Research and innovation > Clinical and pre-Clinical Imaging Laboratory

Clinical and pre-Clinical Imaging Laboratory

Presentation

The “Clinical and pre-clinical Imaging Laboratory” is a translational imaging laboratory, focused on the study of the heart and brain, with a pre-clinical scope.

The mission of the group is the development and application of advanced magnetic resonance imaging (MRI) methods, aimed at improving the diagnosis and evaluation of cardiovascular and neurological diseases.

The laboratory’s research activity is carried out in close collaboration with the Institute of Clinical Physiology of the CNR, and with numerous partners in both the academic and research and industrial fields.

The laboratory is a facility within the Italian molecular imaging node Eurobioimaging, of which the Fondazione Toscana Gabriele Monasterio is a partner.

Areas of Interest

  • Identification of imaging biomarkers specific to disease progression.
  • Development of coils for magnetic resonance imaging.
  • Development and optimisation of magnetic resonance sequences.
  • Tissue characterisation of the myocardium through T1, T2, and T2* mapping.
  • Cardiac magnetic resonance imaging during pharmacological stress, for the work-up of patients with ischaemic heart disease.
  • Early diagnosis and characterisation of rare diseases involving the cardiovascular system.
  • Cerebral spectroscopy with magnetic resonance imaging.
  • Functional magnetic resonance imaging (fMRI) and tractography (DTI), for the work-up of patients with neurological diseases and to investigate brain connectivity.
  • Molecular imaging, for the study of cardiac metabolic activity with the use of non-ionising tracers obtained with the hyperpolarised 13c method.
  • Development of new hyperpolarised contrast media (1H-water and 13C-urea), for the study of myocardial perfusion by cardiovascular magnetic resonance imaging (CMR).
  • Development of innovative high-sensitivity tracers, based on the technique of hyperpolarisation through Dynamic Nuclear Polarisation (DNP).
  • Characterisation and application of innovative contrast media for MRI, for applications of nanomedicine and theranostics (THERApy + diagNOSTICS).
  • Study and characterisation of pathological models on experimental models, using high field magnetic resonance micro-imaging approaches (7 T).
  • Development of signal analysis techniques for noise reduction in imaging, spectroscopy and magnetic resonance relaxometry applications.
  • Development of algorithms for the quantification of spectral parameters of the magnetic resonance signal for spectroscopy and relaxometry applications.

Facilities

  • 1.5T Magnetic Resonance Imaging (GE Healthcare)
  • 1.5T Magnetic Resonance Imaging (GE Healthcare)
  • 3T Magnetic Resonance Imaging (GE Healthcare)
  • NMR 7T spectrometer (Advance HD 300, Bruker), equipped for micro-imaging
  • Dynamic Nuclear Polarisation (DNP) Hypersense Hyperpolariser (Oxford Instruments)
  • Dedicated 1.05 T polarimeter for studies with 13C (Minispec, Bruker)

European Projects

  • Beta-hydroxyBrain: Effect of beta-hydroxybutyrate on cerebral cortex activity (contract 801715).

National and ministerial projects

  • Myocardial perfusion imaging with cardiovascular magnetic resonance and hyperpolarized contrast media. Ministry of Health project GR-2016-02361586.
  • Myocardial perfusion imaging with cardiovascular magnetic resonance and hyperpolarized contrast media. Ministry of Health project GR-2016-02361586.
  • Relationship between osteoporosis and cardiovascular risk in patients with thalassemia major. Ministerial Project GR-2013-02357762.
  • In vivo assessment of the role of Locus Coeruleus in the development of Alzheimer’s Disease and other types of Dementia. Ministerial Project PE-2013-02359574.
  • The sense of number in Developmental Dyscalculia. Ministerial Project GR-2013-02358262.
  • Hyperpolarized 13C-Magnetic Resonance Metabolic Imaging as Sensitive Biomarker in a cardiac translational study of Heart. Ministerial Project RF-2010-2321788.
  • Reorganization of cortical function after surgery for lesional epilepsy in children. Ministerial Project RF-2010-2309954.
  • HTA of diagnostic, instrumental and therapeutic pathways and monitoring of iron build-up (HTA-Thal). FIRB Project.

Projects on corporate/private funds

  • E-MIOT: Extension-Myocardial Iron Overload in Thalassemia.
  • E-MIOT: Extension-Myocardial Iron Overload in Thalassemia.
  • MIOT: Myocardial iron Overload in Thalassemia.
  • MIOMED: Myocardial Iron Overload in MyElodysplastic Diseases.
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.